Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens

Inclusion Criteria: * Must be able to give written informed consent. * Have a diagnosis of cancer and currently receiving chemotherapy containing cisplatin (any dose). * Scheduled to receive antiemetics: granisetron (kytril), hydrocortisone. * Must be able to complete study questionnaires. * Must be able to swallow capsules. Exclusion Criteria: * Have no clinical evidence of current or impending bowel obstruction. * Concurrent radiotherapy that is classified as high or intermediate risk of causing emesis. * Pregnant or lactating. * Patients taking therapeutic doses of coumadin (individuals on low-dose to maintain peripheral or central venous catheters are allowed), aspirin (individuals taking low-dose 80mg aspirin are allowed), or heparin. * Patients with a history of a bleeding disorder(s) in past 6 months and those experiencing thrombocytopenia.